RadioMedix and OncoBeta announce exclusive distribution agreement for W/Re-188 generators in U.S. and Canada

    NEXT STORY
    I-Mab Announces Partial Exercise of Over-Allotment Option in Initial Public Offering
    PREV STORY
    Pressure Ulcer Treatment Market to Reach USD 11.23 Billion by 2026; Rising Geriatric Population to Boost Growth: Fortune Business Insights™
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Corvus Pharmaceuticals to Host R&D Day Highlighting the Role of the Adenosine Pathway in Immuno-Oncology

    BURLINGAME, Calif., March 09, 2017 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (Nasdaq:CRVS), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    Translate Bio Announces FDA Clinical Hold on Investigational New Drug Application (IND) for MRT5201 for the Treatment of Ornithine Transcarbamylase (OTC) Deficiency

    LEXINGTON, Mass., Jan. 22, 2019 (GLOBE NEWSWIRE) -- Translate Bio (Nasdaq: TBIO), a clinical-stage ...

    author_avatar
    NASDAQ Market News

    VBL Therapeutics to Report First Quarter 2017 Results on May 15

    TEL AVIV, Israel, May 03, 2017 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq:VBLT), a clinical-stage ...

    author_avatar
    NASDAQ Market News